<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Ovary, fallopian tube, and primary peritoneal carcinoma TNM staging AJCC UICC 8th edition</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Ovary, fallopian tube, and primary peritoneal carcinoma TNM staging AJCC UICC 8th edition</h1>
<div class="graphic"><div class="figure"><div class="ttl">Ovary, fallopian tube, and primary peritoneal carcinoma TNM staging AJCC UICC 8th edition</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="25%"></colgroup> <tbody> <tr> <td class="subtitle1_left" colspan="4">Primary tumor (T)</td> </tr> <tr class="divider_bottom"> <td><strong>T category</strong></td> <td><strong>FIGO stage</strong></td> <td colspan="2"><strong>T criteria</strong></td> </tr> <tr> <td class="indent1">TX</td> <td> </td> <td colspan="2">Primary tumor cannot be assessed</td> </tr> <tr> <td class="indent1">T0</td> <td> </td> <td colspan="2">No evidence of primary tumor</td> </tr> <tr> <td class="indent1">T1</td> <td>I</td> <td colspan="2">Tumor limited to ovaries (one or both) or fallopian tube(s)</td> </tr> <tr> <td class="indent2">T1a</td> <td>IA</td> <td colspan="2">Tumor limited to one ovary (capsule intact) or fallopian tube, no tumor on ovarian or fallopian tube surface; no malignant cells in ascites or peritoneal washings</td> </tr> <tr> <td class="indent2">T1b</td> <td>IB</td> <td colspan="2">Tumor limited to both ovaries (capsules intact) or fallopian tubes; no tumor on ovarian or fallopian tube surface; no malignant cells in ascites or peritoneal washings</td> </tr> <tr> <td class="indent2">T1c</td> <td>IC</td> <td colspan="2">Tumor limited to one or both ovaries or fallopian tubes, with any of the following:</td> </tr> <tr> <td class="indent3">T1c1</td> <td>IC1</td> <td colspan="2"> <ul class="decimal_heading"> <li>Surgical spill </li> </ul> </td> </tr> <tr> <td class="indent3">T1c2</td> <td>IC2</td> <td colspan="2"> <ul class="decimal_heading"> <li>Capsule ruptured before surgery or tumor on ovarian or fallopian tube surface </li> </ul> </td> </tr> <tr> <td class="indent3">T1c3</td> <td>IC3</td> <td colspan="2"> <ul class="decimal_heading"> <li>Malignant cells in ascites or peritoneal washings </li> </ul> </td> </tr> <tr> <td class="indent1">T2</td> <td>II</td> <td colspan="2">Tumor involves one or both ovaries or fallopian tubes with pelvic extension below pelvic brim or primary peritoneal cancer</td> </tr> <tr> <td class="indent2">T2a</td> <td>IIA</td> <td colspan="2">Extension and/or implants on the uterus and/or fallopian tube(s) and/or ovaries</td> </tr> <tr> <td class="indent2">T2b</td> <td>IIB</td> <td colspan="2">Extension to and/or implants on other pelvic tissues</td> </tr> <tr> <td class="indent1">T3</td> <td>III</td> <td colspan="2">Tumor involves one or both ovaries or fallopian tubes, or primary peritoneal cancer, with microscopically confirmed peritoneal metastasis outside the pelvis and/or metastasis to the retroperitoneal (pelvic and/or para-aortic) lymph nodes</td> </tr> <tr> <td class="indent2">T3a</td> <td>IIIA2</td> <td colspan="2">Microscopic extrapelvic (above the pelvic brim) peritoneal involvement with or without positive retroperitoneal lymph nodes</td> </tr> <tr> <td class="indent2">T3b</td> <td>IIIB</td> <td colspan="2">Macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension with or without metastasis to the retroperitoneal lymph nodes</td> </tr> <tr class="divider_bottom"> <td class="indent2">T3c</td> <td>IIIC</td> <td colspan="2">Macroscopic peritoneal metastasis beyond the pelvis more than 2 cm in greatest dimension with or without metastasis to the retroperitoneal lymph nodes (includes extension of tumor to capsule of liver and spleen without parenchymal involvement of either organ)</td> </tr> <tr class="divider_top"> <td class="subtitle1_left" colspan="4">Regional lymph nodes (N)</td> </tr> <tr class="divider_bottom"> <td><strong>N category</strong></td> <td><strong>FIGO stage</strong></td> <td colspan="2"><strong>N criteria</strong></td> </tr> <tr> <td class="indent1">NX</td> <td> </td> <td colspan="2">Regional lymph nodes cannot be assessed</td> </tr> <tr> <td class="indent1">N0</td> <td> </td> <td colspan="2">No regional lymph node metastasis</td> </tr> <tr> <td class="indent1">N0(i+)</td> <td> </td> <td colspan="2">Isolated tumor cells in regional lymph node(s) no greater than 0.2 mm</td> </tr> <tr> <td class="indent1">N1</td> <td>IIIA1</td> <td colspan="2">Positive retroperitoneal lymph nodes only (histologically confirmed)</td> </tr> <tr> <td class="indent2">N1a</td> <td>IIIA1i</td> <td colspan="2">Metastasis up to and including 10 mm in greatest dimension</td> </tr> <tr class="divider_bottom"> <td class="indent2">N1b</td> <td>IIIA1ii</td> <td colspan="2">Metastasis more than 10 mm in greatest dimension</td> </tr> <tr class="divider_top"> <td class="subtitle1_left" colspan="4">Distant metastasis (M)</td> </tr> <tr class="divider_bottom"> <td><strong>M category</strong></td> <td><strong>FIGO stage</strong></td> <td colspan="2"><strong>M criteria</strong></td> </tr> <tr> <td class="indent1">M0</td> <td> </td> <td colspan="2">No distant metastasis</td> </tr> <tr> <td class="indent1">M1</td> <td>IV</td> <td colspan="2">Distant metastasis, including pleural effusion with positive cytology; liver or splenic parenchymal metastasis; metastasis to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity); and transmural involvement of intestine</td> </tr> <tr> <td class="indent2">M1a</td> <td>IVA</td> <td colspan="2">Pleural effusion with positive cytology</td> </tr> <tr class="divider_bottom"> <td class="indent2">M1b</td> <td>IVB</td> <td colspan="2">Liver or splenic parenchymal metastases; metastases to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity); transmural involvement of intestine</td> </tr> <tr class="divider_top"> <td class="subtitle1_left" colspan="4">Prognostic stage groups</td> </tr> <tr class="divider_bottom"> <td><strong>When T is...</strong></td> <td><strong>And N is...</strong></td> <td><strong>And M is...</strong></td> <td><strong>Then the stage group is...</strong></td> </tr> <tr> <td class="indent1">T1</td> <td>N0</td> <td>M0</td> <td>I</td> </tr> <tr> <td class="indent1">T1a</td> <td>N0</td> <td>M0</td> <td>IA</td> </tr> <tr> <td class="indent1">T1b</td> <td>N0</td> <td>M0</td> <td>IB</td> </tr> <tr> <td class="indent1">T1c</td> <td>N0</td> <td>M0</td> <td>IC</td> </tr> <tr> <td class="indent1">T2</td> <td>N0</td> <td>M0</td> <td>II</td> </tr> <tr> <td class="indent1">T2a</td> <td>N0</td> <td>M0</td> <td>IIA</td> </tr> <tr> <td class="indent1">T2b</td> <td>N0</td> <td>M0</td> <td>IIB</td> </tr> <tr> <td class="indent1">T1/T2</td> <td>N1</td> <td>M0</td> <td>IIIA1</td> </tr> <tr> <td class="indent1">T3a</td> <td>NX, N0, N1</td> <td>M0</td> <td>IIIA2</td> </tr> <tr> <td class="indent1">T3b</td> <td>NX, N0, N1</td> <td>M0</td> <td>IIIB</td> </tr> <tr> <td class="indent1">T3c</td> <td>NX, N0, N1</td> <td>M0</td> <td>IIIC</td> </tr> <tr> <td class="indent1">Any T</td> <td>Any N</td> <td>M1</td> <td>IV</td> </tr> <tr> <td class="indent1">Any T</td> <td>Any N</td> <td>M1a</td> <td>IVA</td> </tr> <tr> <td class="indent1">Any T</td> <td>Any N</td> <td>M1b</td> <td>IVB</td> </tr> </tbody></table></div><div class="graphic_footnotes">TNM: Tumor, Node, Metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control.</div><div class="graphic_reference">Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Corrected at 4th printing, 2018.</div><div id="graphicVersion">Graphic 113545 Version 9.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
